Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for Cytek Biosciences (CTKB) over the last 5 years, with Q3 2025 value amounting to 0.07%.

  • Cytek Biosciences' Return on Invested Capital fell 200.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.05% for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Cytek Biosciences reported Return on Invested Capital of 0.07% as of Q3 2025, which was down 200.0% from 0.06% recorded in Q2 2025.
  • Cytek Biosciences' Return on Invested Capital's 5-year high stood at 0.06% during Q3 2021, with a 5-year trough of 0.09% in Q1 2025.
  • For the 5-year period, Cytek Biosciences' Return on Invested Capital averaged around 0.03%, with its median value being 0.05% (2024).
  • As far as peak fluctuations go, Cytek Biosciences' Return on Invested Capital plummeted by -600bps in 2022, and later surged by 100bps in 2024.
  • Over the past 5 years, Cytek Biosciences' Return on Invested Capital (Quarter) stood at 0.01% in 2021, then crashed by -173bps to 0.01% in 2022, then crashed by -533bps to 0.05% in 2023, then dropped by -4bps to 0.06% in 2024, then decreased by -25bps to 0.07% in 2025.
  • Its last three reported values are 0.07% in Q3 2025, 0.06% for Q2 2025, and 0.09% during Q1 2025.